COVID-19's hidden aftermath: diabetes risk revealed
NCT ID NCT05867017
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigated whether people hospitalized with severe COVID-19 are more likely to develop diabetes later on. Researchers followed 23 participants who had no diabetes before their infection, measuring their blood sugar levels over time. The goal was to understand how COVID-19 might affect long-term metabolic health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Texas Diabetes Institute - University Health System
San Antonio, Texas, 78207, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?